Previously Unreported Chromosomal Aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a Patient with Accelerated Phase Ph+ CML
- PMID: 24711936
- PMCID: PMC3965933
- DOI: 10.1155/2014/582016
Previously Unreported Chromosomal Aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a Patient with Accelerated Phase Ph+ CML
Abstract
Chronic myelogenous leukemia (CML) is a clonal hematological disorder, which is characterized by the presence of the classical or variant Philadelphia translocations. During the progression to blastic phase of the disease secondary chromosomal abnormalities may emerge. Such secondary chromosomal abnormalities are nonrandom, the more frequent ones being trisomy 8 and 19, supernumerary i(17q), and extra Philadelphia chromosomes. Furthermore, a minor percentage of the patients may acquire different secondary chromosomal abnormalities including translocations between other chromosomes. We report here a patient with Ph+ CML presenting secondary chromosomal abnormalities including t(4;11)(q21;q23), t(3;3)(q29;q23) and t(11;18)(q10;q10) during the course of CML progression.
Figures
Similar articles
-
Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression.Genes Chromosomes Cancer. 2002 Oct;35(2):127-37. doi: 10.1002/gcc.10099. Genes Chromosomes Cancer. 2002. PMID: 12203776
-
Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.Cancer Genet Cytogenet. 1999 Jan 1;108(1):6-12. doi: 10.1016/s0165-4608(98)00120-4. Cancer Genet Cytogenet. 1999. PMID: 9973917
-
A novel t(3;12)(q21;p13) translocation in a patient with accelerated chronic myeloid leukemia after imatinib and nilotinib therapy.Cancer Biol Med. 2013 Mar;10(1):47-51. doi: 10.7497/j.issn.2095-3941.2013.01.008. Cancer Biol Med. 2013. PMID: 23691445 Free PMC article.
-
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.Acta Haematol. 2002;107(2):76-94. doi: 10.1159/000046636. Acta Haematol. 2002. PMID: 11919388 Review.
-
The cytogenetic scenario of chronic myeloid leukemia.Leuk Lymphoma. 1993;11 Suppl 1:11-5. doi: 10.3109/10428199309047856. Leuk Lymphoma. 1993. PMID: 8251885 Review.
Cited by
-
Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis.J Hematol Oncol. 2015 Apr 8;8:32. doi: 10.1186/s13045-015-0128-2. J Hematol Oncol. 2015. PMID: 25888368 Free PMC article.
References
-
- Johansson B, Fioretos T, Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematologica. 2002;107(2):76–94. - PubMed
-
- Meza Espinoza JP, Picos Cárdenas VJ, Gutiérrez-Angulo M, González García JR. Secondary chromosomal changes in 34 Philadelphia-chromosome-positive chronic myelocytic leukemia patients from the Mexican West. Cancer Genetics and Cytogenetics. 2004;148(2):166–169. - PubMed
-
- de Oliveira FM, de Carvalho Palma L, Falcão RP, Simões BP. A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia. Medical Oncology. 2012;29(4):2332–2336. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources